WU
28
-14
AMG
44
-5
WY
30
3
IFF
41
8
NSC
48
11
VLO
33
5
EQT
42
5
AEE
76
3
WFC
63
3
ED
45
2
PGR
54
-5
ESS
40
3
MUR
27
5
MAC
47
4
SO
62
5
RL
62
6
AME
42
-3
EQIX
55
2
JPM
59
4
VZ
52
5
WU
28
-14
AMG
44
-5
WY
30
3
IFF
41
8
NSC
48
11
VLO
33
5
EQT
42
5
AEE
76
3
WFC
63
3
ED
45
2
PGR
54
-5
ESS
40
3
MUR
27
5
MAC
47
4
SO
62
5
RL
62
6
AME
42
-3
EQIX
55
2
JPM
59
4
VZ
52
5
Financhill
Back

Mirum Pharmaceuticals 10K Form

Sell
25

MIRM
Mirum Pharmaceuticals

Last Price:
$38.41
Seasonality Move:
14.7%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MIRM News And Ratings

See the #1 stock for the next 7 days that we like better than MIRM

MIRM Financial Statistics

Sales & Book Value

Annual Sales: $336.9M
Cash Flow: $-5.1M
Price / Cash Flow: 0
Annual Sales: $4.67
Price / Book: 8.49

Profitability

EPS (TTM): -1.85220
Net Income (TTM): $-87.9M
Gross Margin: $255.2M
Return on Equity: -37.59%
Return on Assets: -13.33%

Mirum Pharmaceuticals Earnings Forecast

Key Mirum Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 5 years for MIRM is 75.77%.
  • The Selling, General & Administrative Expenses for MIRM have been equal to 60.03% of Gross Profit Margin.
  • The Research & Development expenses have been 41.74% of Revenue.
  • The Net Earning history of MIRM is -26.10% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 4 years.

Mirum Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: MIRM
CUSIP: 604749
Website: mirumpharma.com

Debt

Debt-to-Equity Ratio: 1.37
Current Ratio: 3.1
Quick Ratio: 2.83

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 52.26

MIRM Technical Analysis vs Fundamental Analysis

Sell
25
Mirum Pharmaceuticals (MIRM) is a Sell

Is Mirum Pharmaceuticals a Buy or a Sell?